These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15719399)

  • 21. [Severe, life-threatening renal anemia treatment in patients who do not accept heterologous blood transfusion for religious reasons--case report].
    Jaroszyński AJ; Bober-Palak E; Jóźwiak L; Ksiazek A
    Przegl Lek; 2007; 64(7-8):528-30. PubMed ID: 18409359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatment.
    Gaya A; Urbano-Ispizua A; Fernández-Avilés F; Salamero O; Roncero JM; Rovira M; Martínez C; Talarn C; Granell M; Carreras E; Montserrat E
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):880-7. PubMed ID: 18640571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eprex approved for anemia in AIDS patients.
    Oncology (Williston Park); 1989 Sep; 3(9):79. PubMed ID: 2641692
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythropoietin as a protective agent in myocardial ischemia].
    Schwartzenberg S; Keren G; George J
    Harefuah; 2006 May; 145(5):380-3, 396. PubMed ID: 16805223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
    Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
    Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
    Eliopoulos N; Gagnon RF; Francois M; Galipeau J
    J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finding a rational approach to ESA therapy--for payers and patients.
    Messana A
    Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
    [No Abstract]   [Full Text] [Related]  

  • 30. New Zealand cancer patients should have access to erythropoietin treatment.
    Carter J; Clay J
    N Z Med J; 2006 May; 119(1234):U1989. PubMed ID: 16718300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of anemia caused by chronic kidney failure in adults].
    Nephrol Ther; 2005 Aug; 1 Suppl 1():S1-48. PubMed ID: 16895707
    [No Abstract]   [Full Text] [Related]  

  • 32. [Erythropoietic protein supportive treatment in small cell lung cancer].
    Tamási L; Müller V; Magyar P; Losonczy G
    Magy Onkol; 2008 Mar; 52(1):43-6. PubMed ID: 18403296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heart failure: erythropoietin in treatment of anemia].
    Büyüklü M
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):342-3. PubMed ID: 17785241
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anemia and the role of erythropoietin in diabetes.
    McGill JB; Bell DS
    J Diabetes Complications; 2006; 20(4):262-72. PubMed ID: 16798479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor response to erythropoietin: practical guidelines on investigation and management.
    Macdougall IC
    Nephrol Dial Transplant; 1995; 10(5):607-14. PubMed ID: 7566570
    [No Abstract]   [Full Text] [Related]  

  • 38. Anemia of chronic kidney disease and end-stage renal disease: are there unique issues in disadvantaged populations?
    Obrador GT
    Ethn Dis; 2009; 19(1 Suppl 1):S1-52-5. PubMed ID: 19484876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism.
    Trunzo JA; McHenry CR; Schulak JA; Wilhelm SM
    Surgery; 2008 Dec; 144(6):915-8; discussion 919. PubMed ID: 19040997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.